|
Obagi Medical Products, Inc. - Company Profile Snapshot
| Company Profile: |
Obagi Medical Products, Inc. |
| Ticker: |
OMPI |
| Exchanges: |
NAS |
| 2008 Sales: |
104,590,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
218 |
Business Description
Obagi Medical Products, Inc.. The Group's principal activity is to develop and market prescription-based, topical skin health systems in the aesthetic and therapeutic skin health markets. It helps physicians to treat a range of skin conditions, including pre-mature aging, photo-damage, hyper pigmentation, acne and soft tissue deficits, such as fine lines and wrinkles. Its product lines are prescription-based skin health systems that improve the efficacy of established prescription and over-the-counter, therapeutic agents by enhancing the penetration of these agents across the skin barrier using proprietary technologies. It also licenses certain non-prescription product concepts under the Obagi trademark to a large Japanese based Pharmaceutical company. The Group introduced ELASTIdermTM product line, ELASTIdermTM Eye Cream, a for treatment of skin laxity around the eye.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
